BioRestorative Net Receivables from 2010 to 2025

BRTX Stock  USD 1.52  0.10  6.17%   
BioRestorative Therapies Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables is likely to outpace its year average in 2025. During the period from 2010 to 2025, BioRestorative Therapies Net Receivables regression line of annual values had r-squared of  0.71 and arithmetic mean of  47,620. View All Fundamentals
 
Net Receivables  
First Reported
2015-06-30
Previous Quarter
27.4 K
Current Value
165 K
Quarterly Volatility
28.2 K
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.7 M or Depreciation And Amortization of 178.1 K, as well as many indicators such as Price To Sales Ratio of 54.99, Dividend Yield of 0.0 or PTB Ratio of 0.69. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of BioRestorative Therapies over the last few years. It is BioRestorative Therapies' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

BioRestorative Net Receivables Regression Statistics

Arithmetic Mean47,620
Geometric Mean32,304
Coefficient Of Variation78.77
Mean Deviation34,316
Median32,000
Standard Deviation37,509
Sample Variance1.4B
Range88.4K
R-Value(0.84)
Mean Square Error443.2M
R-Squared0.71
Significance0.000046
Slope(6,620)
Total Sum of Squares21.1B

BioRestorative Net Receivables History

202522 K
202417.4 K
202319.3 K
202216 K
2021 5000.0
202017 K
201932 K

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables17.4 K22 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.